首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Prediction of Nodal Involvement in Breast Cancer Based on Multiparametric Protein Analyses from Preoperative Core Needle Biopsies of the Primary Lesion.
【24h】

Prediction of Nodal Involvement in Breast Cancer Based on Multiparametric Protein Analyses from Preoperative Core Needle Biopsies of the Primary Lesion.

机译:基于术前原发灶核心穿刺活检的多参数蛋白质分析,可预测乳腺癌的淋巴结转移情况。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Identification of molecular characteristics that are useful to define subgroups of patients fitting into differential treatment schemes is considered a most promising approach in cancer research. In this first study of such type, we therefore investigated the potential of multiplexed sandwich immunoassays to define protein expression profiles indicative of clinically relevant properties of malignant tumors. EXPERIMENTAL DESIGN: Lysates prepared from large core needle biopsies of 113 invasive breast carcinomas were analyzed with bead-based miniaturized sandwich immunoassays specific for 54 preselected proteins. RESULTS: Five protein concentrations [fibroblast growth factor-2 (FGF-2), Fas, Fas ligand, tissue inhibitor of metalloproteinase-1, and RANTES] were significantly different in the groups of patients with or without axillary lymph node metastasis. All 15 protein parameters that resulted in P values <0.2 and other diagnostic information [estrogen receptor (ER) status, tumor size, and histologic grading] were analyzed together by multivariate logistic regression. This yielded sets of five (FGF-2, Fas, Fas ligand, IP10, and PDGF-AB/BB) or six (ER staining intensity, FGF-2, Fas ligand, matrix metalloproteinase-13, PDGF-AB/BB, and IP10) parameters for which receiver-operator characteristic analyses revealed high sensitivities and specificities [area under curve (AUC) = 0.75 and AUC = 0.83] to predict the nodal status. A similar analysis including all identified parameters of potential value (15 proteins, ER staining intensity, T) without selection resulted in a receiver-operator characteristic curve with an AUC of 0.87. CONCLUSION: We clearly showed that this approach can be used to quantify numerous proteins from breast biopsies accurately in parallel and define sets of proteins whose combined analyses allow the prediction of nodal involvement with high specificity and sensitivity.
机译:目的:鉴定可用于确定适合不同治疗方案的患者亚组的分子特征在癌症研究中被认为是最有前途的方法。因此,在此类首次研究中,我们研究了多重夹心免疫分析法定义蛋白质表达谱的可能性,这些蛋白表达谱指示了恶性肿瘤的临床相关特性。实验设计:用针对54种预选蛋白的基于微珠的微型夹心免疫分析法对从113种浸润性乳腺癌的大芯针活检组织中制备的裂解物进行了分析。结果:在有或没有腋窝淋巴结转移的患者组中,五种蛋白质浓度[成纤维细胞生长因子2(FGF-2),Fas,Fas配体,金属蛋白酶-1的组织抑制剂和RANTES]有显着差异。通过多元logistic回归分析了导致P值<0.2的所有15种蛋白质参数和其他诊断信息[雌激素受体(ER)状态,肿瘤大小和组织学分级]。这产生了五组(FGF-2,Fas,Fas配体,IP10和PDGF-AB / BB)或六组(ER染色强度,FGF-2,Fas配体,基质金属蛋白酶-13,PDGF-AB / BB和接收器-操作员特性分析显示出很高的灵敏度和特异性[IP10]参数[曲线下面积(AUC)= 0.75和AUC = 0.83]可预测节点状态。包括所有已确定的潜在值参数(15种蛋白质,ER染色强度,T)的未经选择的相似分析,得出的接收者-操作者特征曲线的AUC为0.87。结论:我们清楚地表明,该方法可用于并行,准确地定量乳腺活检中的多种蛋白质,并定义蛋白质组合,这些蛋白质的组合分析可以高度特异性和灵敏地预测淋巴结转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号